Company intelligence / Profile preview

Shorewind Capital

Burlingame, California, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Shorewind Capital is an active US-based venture capital firm founded in 2021 that invests in early-stage, cutting-edge technology companies, sometimes including health or life science ventures, but it is not itself a biotech/pharma/healthcare company. Key leadership includes Jake Poliskin, Nick Fragnito, Andrew Rubenstein, with David Rubenstein serving as an anchor. Their investment scope is broad, supporting innovation intended to have global impact, with offices in California (Burlingame) and Georgia (Atlanta).

Industry: Investors

Beyond the preview

Go deeper on Shorewind Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shorewind Capital.

Explore the full profile